← Back to Search

Behavioral Intervention

Executive Function Group Therapy for Autism Spectrum Disorder

N/A
Waitlist Available
Research Sponsored by Children's National Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Intact or corrected hearing and vision.
14-18 years of age inclusive
Must not have
To preserve the integrity of the neuroimaging data, participants will be excluded if they have a history of neurological disorder, such as an established epilepsy diagnosis, significant brain trauma, hydrocephalus, central nervous system infection, or stroke.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8-12 months before intervention, at start of intervention, 8-12 months after intervention begins, 8-12 months after intervention ends
Awards & highlights

Summary

This trial is testing whether a cognitive behavioral intervention can help improve flexibility in ASD by looking at changes in learning and associated neural activation.

Who is the study for?
This trial is for adolescents aged 14-18 with Autism Spectrum Disorder who have an IQ over 80 and can communicate effectively in English. They must meet specific criteria on autism diagnostic tools and have normal or corrected hearing and vision. Those with metal implants, braces, pregnancy, significant neurological issues, or conditions affecting study participation are excluded.
What is being tested?
The trial tests if executive function group therapy can improve learning flexibility in teens with ASD using brain scans (m-fMRI) to observe changes. It's a long-term study where participants are assessed three times over eight months to see how the therapy affects their brain activity and behavior.
What are the potential side effects?
Since this is a behavioral intervention involving cognitive exercises rather than medication, traditional side effects like those seen with drugs are not expected. However, participants may experience fatigue or discomfort from repetitive tasks or the MRI procedure.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My hearing and vision are normal or corrected to normal.
Select...
I am between 14 and 18 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not have a history of major brain conditions like epilepsy, severe injury, infections, or stroke.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8-12 months before intervention, at start of intervention, 8-12 months after intervention begins
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8-12 months before intervention, at start of intervention, 8-12 months after intervention begins for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Executive Function Challenge Task (EFCT) Scores
Change in Neural Response During Prototype Learning Task Outcomes
Secondary study objectives
Change in Adaptive Behavior Assessment System, Third Edition (ABAS-3) scores
Other study objectives
Change in AIR-SDS Scores
Change in ASC - ASD Scores
Change in BDI-II Scores
+8 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Executive function group therapyExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
2,014 Previous Clinical Trials
2,696,770 Total Patients Enrolled
36 Trials studying Autism Spectrum Disorder
9,962 Patients Enrolled for Autism Spectrum Disorder
Children's National Research InstituteLead Sponsor
218 Previous Clinical Trials
257,846 Total Patients Enrolled
2 Trials studying Autism Spectrum Disorder
292 Patients Enrolled for Autism Spectrum Disorder
Georgetown UniversityOTHER
346 Previous Clinical Trials
137,146 Total Patients Enrolled
2 Trials studying Autism Spectrum Disorder
216 Patients Enrolled for Autism Spectrum Disorder

Media Library

Executive function group therapy (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05131659 — N/A
Autism Spectrum Disorder Research Study Groups: Executive function group therapy
Autism Spectrum Disorder Clinical Trial 2023: Executive function group therapy Highlights & Side Effects. Trial Name: NCT05131659 — N/A
Executive function group therapy (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05131659 — N/A
~19 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top